GSK submits US regulatory application for mepolizumab in eosinophilic chronic obstructive pulmonary disease (COPD)
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced the submission of a supplemental Biologics License Application (sBLA) to the United States Food and Drug Administration (FDA
New multi-country survey reveals need for improved awareness around long-term impact and appropriate use of corticosteroids in SLE management
Results from EnABLE highlight an opportunity for increased awareness on appropriate corticosteroid use and a more proactive approach to the management of SLE.
ViiV Healthcare announces positive phase 3 results from the BRIGHTE study of fostemsavir in heavily treatment-experienced patients with HIV
ViiV Healthcare, today announced results from the phase III BRIGHTE study of fostemsavir in heavily treatment-experienced (HTE) patients with HIV-1 infection.
Lawrence Livermore National Laboratory, Frederick National Laboratory for Cancer Research, GSK, and University of California San Francisco will combine vast data stores, supercomputing, and scientific expertise to reinvent discovery process for cancer medicines